|
US6090406A
(en)
*
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5916588A
(en)
*
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
JPH0832637B2
(ja)
*
|
1985-02-14 |
1996-03-29 |
アクゾ・エヌ・ヴエー |
合成免疫原
|
|
DE3601136A1
(de)
*
|
1986-01-16 |
1987-07-23 |
Max Planck Gesellschaft |
Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
|
|
US4803070A
(en)
*
|
1986-04-15 |
1989-02-07 |
Ribi Immunochem Research Inc. |
Immunological emulsion adjuvants for polysaccharide vaccines
|
|
US5554372A
(en)
*
|
1986-09-22 |
1996-09-10 |
Emory University |
Methods and vaccines comprising surface-active copolymers
|
|
US6054438A
(en)
*
|
1987-01-07 |
2000-04-25 |
Imperial Cancer Research Technology Limited |
Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin
|
|
US5434182A
(en)
*
|
1987-12-31 |
1995-07-18 |
Isaacs; Charles E. |
Antibacterial fatty acid compositions
|
|
US4997851A
(en)
*
|
1987-12-31 |
1991-03-05 |
Isaacs Charles E |
Antiviral and antibacterial activity of fatty acids and monoglycerides
|
|
US5466714A
(en)
*
|
1987-12-31 |
1995-11-14 |
Research Foundation For Mental Health Hygiene, Inc. |
Spermicidal and cytocidal fatty acid compositions
|
|
EP0324455A3
(en)
*
|
1988-01-15 |
1991-03-27 |
Hans O. Ribi |
Novel polymeric immunological adjuvants
|
|
ES2019728A6
(es)
*
|
1988-09-23 |
1991-07-01 |
Univ Southern California |
Procedimiento de preparacion de una vacuna de inmunoterapia para tumores de melanoma.
|
|
FI902821A7
(fi)
*
|
1989-06-12 |
1990-12-13 |
Res Foundation For Mental Hygiene |
Infektion leviämisen vähentäminen verenkäsittelylaitteistolla
|
|
DE4007315A1
(de)
*
|
1990-03-08 |
1991-09-12 |
Behringwerke Ag |
Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen
|
|
US5091188A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
US5246707A
(en)
*
|
1990-04-26 |
1993-09-21 |
Haynes Duncan H |
Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
|
|
SK100893A3
(en)
|
1991-03-19 |
1994-04-06 |
Cytrx Corp |
Polyoxypropylene-polyoxyethylene copolymers with improved biological activity
|
|
US5688761A
(en)
*
|
1991-04-19 |
1997-11-18 |
Lds Technologies, Inc. |
Convertible microemulsion formulations
|
|
ES2136620T3
(es)
*
|
1991-04-19 |
1999-12-01 |
Lds Technologies Inc |
Formulaciones de microemulsiones convertibles.
|
|
IL105325A
(en)
*
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
FR2702373B1
(fr)
*
|
1993-03-08 |
1996-06-07 |
Rhone Merieux |
Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable.
|
|
US5776468A
(en)
*
|
1993-03-23 |
1998-07-07 |
Smithkline Beecham Biologicals (S.A.) |
Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A
|
|
CA2163652A1
(en)
*
|
1993-05-27 |
1994-12-08 |
Carol A. Nacy |
Compositions and methods for treating cancer and hyperproliferative disorders
|
|
US5690942A
(en)
*
|
1995-06-02 |
1997-11-25 |
American Home Products Corporation |
Adjuvants for viral vaccines
|
|
US5718904A
(en)
*
|
1995-06-02 |
1998-02-17 |
American Home Products Corporation |
Adjuvants for viral vaccines
|
|
WO1997014407A1
(en)
|
1995-10-17 |
1997-04-24 |
Research Triangle Pharmaceuticals |
Insoluble drug delivery
|
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
|
US5849307A
(en)
*
|
1997-03-26 |
1998-12-15 |
The Picower Institute For Medical Research |
Vaccine adjuvant
|
|
US6455323B1
(en)
|
1997-07-03 |
2002-09-24 |
Pharmacia & Upjohn Company |
Anti-bacterial methods and materials
|
|
DE69908304T2
(de)
*
|
1998-02-11 |
2004-02-19 |
Rtp Pharma Corp. |
Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
HK1039458B
(zh)
|
1998-05-29 |
2006-09-01 |
Skyepharma Canada Inc. |
熱保護微粒組合物及其最終蒸汽滅菌的方法
|
|
WO2000010531A1
(en)
*
|
1998-08-19 |
2000-03-02 |
Rtp Pharma Inc. |
Injectable aqueous dispersions of propofol
|
|
GB2348203B
(en)
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Solube beta-forms of prion proteins, methods of preparation and use
|
|
WO2000030616A1
(en)
*
|
1998-11-20 |
2000-06-02 |
Rtp Pharma Inc. |
Dispersible phospholipid stabilized microparticles
|
|
US6790950B2
(en)
|
1999-04-09 |
2004-09-14 |
Pharmacia & Upjohn Company |
Anti-bacterial vaccine compositions
|
|
CN1351653A
(zh)
|
1999-04-09 |
2002-05-29 |
法玛西雅厄普约翰美国公司 |
抗细菌疫苗组合物
|
|
CA2383233C
(en)
*
|
1999-09-21 |
2010-06-08 |
Rtp Pharma Inc. |
Surface modified particulate compositions of biologically active substances
|
|
EP1267899B1
(en)
|
2000-03-17 |
2005-08-03 |
Pharmacia & Upjohn Company LLC |
Ssa inactivated salmonella vaccines
|
|
WO2001077365A2
(en)
|
2000-04-06 |
2001-10-18 |
Pharmacia & Upjohn Company |
Antimicrobial methods and materials
|
|
CA2407027C
(en)
|
2000-04-20 |
2011-02-15 |
Rtp Pharma Inc. |
Improved water-insoluble drug particle process
|
|
US7323174B1
(en)
|
2000-06-12 |
2008-01-29 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Modulation of immune response and methods based thereon
|
|
ES2325057T3
(es)
|
2000-08-31 |
2009-08-25 |
Jagotec Ag |
Particulas molturadas.
|
|
ES2372746T3
(es)
*
|
2000-09-20 |
2012-01-26 |
Jagotec Ag |
Micropartículas de fibrato estabilizadas.
|
|
US8586094B2
(en)
*
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
|
TWI288000B
(en)
*
|
2001-02-22 |
2007-10-11 |
Rtp Pharma Inc |
Fibrate-statin combinations with reduced fed-fasted effects
|
|
FR2824279B1
(fr)
*
|
2001-05-04 |
2004-05-28 |
Seppic Sa |
Emulsion e/h concentree
|
|
GB0112126D0
(en)
|
2001-05-18 |
2001-07-11 |
Allergene Inc |
Composition
|
|
FR2824269B1
(fr)
*
|
2001-09-03 |
2012-03-02 |
Seppic Sa |
Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras
|
|
ES2391770T3
(es)
|
2003-01-21 |
2012-11-29 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos de triptantrina para la potenciación inmune
|
|
ES2423800T3
(es)
|
2003-03-28 |
2013-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos orgánicos para la inmunopotenciación
|
|
GB0315323D0
(en)
|
2003-07-01 |
2003-08-06 |
Royal Veterinary College |
Vaccine composition
|
|
US9023366B2
(en)
|
2003-07-01 |
2015-05-05 |
The Royal Veterinary College |
Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
|
|
US20110104186A1
(en)
|
2004-06-24 |
2011-05-05 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
|
CA2571421A1
(en)
|
2004-06-24 |
2006-01-05 |
Nicholas Valiante |
Compounds for immunopotentiation
|
|
US20060210590A1
(en)
|
2005-02-03 |
2006-09-21 |
Alk-Abello A/S |
Minor allergen control to increase safety of immunotherapy
|
|
ES2376492T3
(es)
|
2006-03-23 |
2012-03-14 |
Novartis Ag |
Compuestos de imidazoquinoxalina como inmunomoduladores.
|
|
CA2646891A1
(en)
*
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Immunopotentiating compounds
|
|
CA2647100A1
(en)
*
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Methods for the preparation of imidazole-containing compounds
|
|
CN101827613A
(zh)
|
2007-09-27 |
2010-09-08 |
免疫疫苗技术有限公司 |
在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
CN102056622B
(zh)
|
2008-06-05 |
2016-04-06 |
免疫疫苗技术有限公司 |
包含脂质体、抗原、多核苷酸和含疏水物质的连续相的载体的组合物
|
|
SI2364314T1
(sl)
|
2008-12-09 |
2014-07-31 |
Gilead Sciences, Inc. |
Modulatorji Tollu podobnih receptorjev
|
|
US8464405B2
(en)
|
2010-01-29 |
2013-06-18 |
Kabushiki Kaisha Mikimoto |
Jewelry clasp
|
|
AU2011252850B2
(en)
|
2010-05-14 |
2016-03-17 |
Baxalta GmbH |
OspA chimeras and use thereof in vaccines
|
|
WO2012010290A1
(en)
|
2010-07-21 |
2012-01-26 |
Athera Biotechnologies Ab |
Diagnostic and therapeutic methods and compositions for metabolic disease
|
|
WO2012010291A1
(en)
|
2010-07-21 |
2012-01-26 |
Athera Biotechnologies Ab |
Diagnostic and therapeutic methods and compositions for metabolic disease
|
|
JP2014500267A
(ja)
|
2010-12-08 |
2014-01-09 |
ネオヴァクス |
強力に不活性化されているがなお高い免疫原性を示すワクチンおよびその製造方法
|
|
EP2462950A1
(en)
|
2010-12-08 |
2012-06-13 |
Neovacs |
Strongly inactivated and still highly immunogenic vaccine, and process of manufacturing thereof
|
|
MX348380B
(es)
|
2011-04-07 |
2017-06-09 |
Neovacs |
Pruducto inmunogénico para usarse en vacunas.
|
|
EP2508197A1
(en)
|
2011-04-07 |
2012-10-10 |
Neovacs |
Method for treating IFNalpha related conditions
|
|
ES2855474T3
(es)
|
2011-10-06 |
2021-09-23 |
Immunovaccine Technologies Inc |
Composiciones de liposomas que comprenden un adyuvante que activa o incrementa la actividad de TLR2 y usos del mismo
|
|
GB201200259D0
(en)
|
2012-01-09 |
2012-02-22 |
Ohlin Per M |
Novel therapies
|
|
WO2014018274A1
(en)
|
2012-07-27 |
2014-01-30 |
Baxter International, Inc. |
Compositions comprising chimeric ospa molecules and methods of use thereof
|
|
WO2016001907A1
(en)
|
2014-07-02 |
2016-01-07 |
Prendergast Patrick T |
Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
|
|
CA2963437A1
(en)
|
2014-10-15 |
2016-04-21 |
Xenothera |
Composition with reduced immunogenicity
|
|
AR114911A1
(es)
|
2018-06-04 |
2020-10-28 |
Apros Therapeutics Inc |
Conjugados peptídicos de tlr7
|
|
KR20210027381A
(ko)
|
2018-07-02 |
2021-03-10 |
아유비스 리서치, 인코포레이티드 |
신규 면역조절 소분자
|
|
EP3922255A1
(en)
|
2020-06-10 |
2021-12-15 |
Prokarium Limited |
Cancer therapy
|
|
GB202009411D0
(en)
|
2020-06-19 |
2020-08-05 |
Prokarium Ltd |
Autotransporter systems
|
|
CN112807426A
(zh)
*
|
2021-01-26 |
2021-05-18 |
郭志文 |
一种基于动物疫苗的聚合物佐剂、制备方法及其应用
|
|
EP4124342A1
(en)
|
2021-07-28 |
2023-02-01 |
Prokarium Limited |
Cancer therapy with live attenuated bacteria
|
|
US20240424086A1
(en)
|
2021-09-07 |
2024-12-26 |
Universite De Tours |
Coronavirus fusion protein
|
|
GB202215134D0
(en)
|
2022-10-13 |
2022-11-30 |
Prokarium Ltd |
Composition
|
|
GB202215576D0
(en)
|
2022-10-21 |
2022-12-07 |
Prokarium Ltd |
Circuit
|
|
WO2025068413A1
(en)
|
2023-09-28 |
2025-04-03 |
Prokarium Limited |
Interleukin 18 variants
|
|
WO2025068401A1
(en)
|
2023-09-28 |
2025-04-03 |
Prokarium Limited |
Interleukin 15 variant
|
|
WO2025109155A1
(en)
|
2023-11-24 |
2025-05-30 |
Prokarium Limited |
Interleukin variant
|
|
GB202405780D0
(en)
|
2024-04-24 |
2024-06-05 |
Prokarium Ltd |
Vacuole escape
|
|
WO2025224251A1
(en)
|
2024-04-24 |
2025-10-30 |
Prokarium Limited |
Modified microorganisms
|